Daniel Shevrin to Female
This is a "connection" page, showing publications Daniel Shevrin has written about Female.
Connection Strength
0.049
-
An item bank was created to improve the measurement of cancer-related fatigue. J Clin Epidemiol. 2005 Feb; 58(2):190-7.
Score: 0.013
-
Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial. Eur J Cancer. 2019 06; 114:107-116.
Score: 0.008
-
Phase II trial of 6-thioguanine in advanced renal cell carcinoma. An Illinois Cancer Center study. Invest New Drugs. 1994; 12(4):345-6.
Score: 0.006
-
Phase II trial of fludarabine phosphate in advanced renal cell carcinoma: an Illinois Cancer Council Study. Invest New Drugs. 1989 Jul; 7(2-3):251-3.
Score: 0.004
-
Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manage. 2008 Jan; 35(1):20-30.
Score: 0.004
-
Longitudinal screening and management of fatigue, pain, and emotional distress associated with cancer therapy. Support Care Cancer. 2008 Feb; 16(2):151-9.
Score: 0.004
-
Phase II trial of aminothiadiazole in advanced non-small cell lung cancer. Cancer Treat Rep. 1986 Mar; 70(3):417-8.
Score: 0.003
-
Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancer. Lung Cancer. 2003 Feb; 39(2):221-6.
Score: 0.003
-
Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586). Am J Clin Oncol. 2000 Aug; 23(4):371-5.
Score: 0.002
-
Assessment of coagulation system activation using spot urine measurements. Blood Coagul Fibrinolysis. 1999 Jul; 10(5):285-9.
Score: 0.002